Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Toxic erythema of chemotherapy.

Repass TS, Wetter DA, Camilleri MJ.

Am J Hematol. 2012 Sep;87(9):923. doi: 10.1002/ajh.22200. Epub 2011 Nov 10. No abstract available.

2.

Paclitaxel-induced acral erythema.

Richards KN, Ivan D, Rashid RM, Chon SY.

Arch Dermatol. 2012 Nov;148(11):1333-4. doi: 10.1001/archdermatol.2012.2830. No abstract available.

PMID:
23165853
3.

[Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma].

Wolf M, Faoro C, Görg C, Merte H, Pfab R, Diergarten K, Havemann K.

Strahlenther Onkol. 1996 May;172 Suppl 1:5-8. German. No abstract available.

PMID:
8633270
4.

[Taxol in bronchial carcinoma].

Gatzemeier U.

Med Klin (Munich). 1996 Dec 15;91 Suppl 2:1-6. Review. German. No abstract available.

PMID:
9082171
5.

[Taxol and simultaneous radiotherapy in stage IIIA and IIIB, locally advanced, non-small-cell bronchial carcinoma. Phase-I clinical trial].

Vogt HG, Kolotas C, Martin T, Schneider LV, Goes-Schmieder R, Mitrou PS, Kettner H, Kober B, Zamboglou N.

Strahlenther Onkol. 1996 May;172 Suppl 1:9-15. German. No abstract available.

PMID:
8633271
7.

[Aeroportia and necrotizing enteritis after chemotherapy with paclitaxel for lung carcinoma].

Benoit L, Favoulet P, Fraisse J, Feutray S, Collin F, Chauffert B, Cuisenier J.

Gastroenterol Clin Biol. 2003 Apr;27(4):423-4. French. No abstract available.

8.

[Paclitaxel].

Díaz M, Campanero MA.

Rev Med Univ Navarra. 1996 Jul-Sep;40(3):43-51. Review. Spanish. No abstract available.

PMID:
9499826
9.

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.

Ceresoli GL, Gregorc V, Cordio S, Bencardino KB, Schipani S, Cozzarini C, Bordonaro R, Villa E.

Lung Cancer. 2004 May;44(2):231-9.

PMID:
15084388
10.

Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.

Hainsworth JD, Greco FA.

Semin Oncol. 1995 Dec;22(6 Suppl 15):45-9.

PMID:
8643970
11.

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR.

Cancer. 2003 May 15;97(10):2480-6.

12.

The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.

Gasparini G, Meo S, Comella G, Stani SC, Mariani L, Gamucci T, Avallone A, Lo Vullo S, Mansueto G, Bonginelli P, Gattuso D, Gion M.

Cancer J. 2005 May-Jun;11(3):209-16.

PMID:
16053664
13.

Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.

Gatzemeier U, Heckmayer M, Neuhauss R, Schlüter I, von Pawel J, Wagner H, Dreps A.

Semin Oncol. 1995 Dec;22(6 Suppl 15):24-8.

PMID:
8643966
14.

First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer.

Tummarello D, Lippe P, Bracci R, Mari D, Monterubbianesi MC, Battelli N.

Oncol Rep. 1998 Jul-Aug;5(4):897-900.

PMID:
9625841
15.

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).

Scagliotti GV, Smit E, Bosquee L, O'Brien M, Ardizzoni A, Zatloukal P, Eberhardt W, Smid-Geirnaerdt M, de Bruin HG, Dussenne S, Legrand C, Giaccone G; European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group (LCG).

Lung Cancer. 2005 Oct;50(1):91-6.

16.

Preliminary results of radiotherapy with or without weekly paclitaxel in locally advanced non-small cell lung cancer.

Cüneyt Ulutin H, Pak Y.

J Cancer Res Clin Oncol. 2003 Jan;129(1):52-6. Epub 2003 Jan 31.

PMID:
12618901
17.

Chemotherapy-induced acral erythema sparing the palms.

Housholder AL, Adams BB.

J Am Acad Dermatol. 2012 Sep;67(3):e116-7. doi: 10.1016/j.jaad.2011.09.031. No abstract available.

PMID:
22890739
18.

Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments.

Yasuda K, Igishi T, Kawasaki Y, Kato K, Matsumoto S, Katayama S, Sako T, Shigeoka Y, Suyama H, Sugitani A, Yamamoto M, Hitsuda Y, Shimizu E.

Oncology. 2004;66(5):347-52.

PMID:
15331920
19.

Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).

Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D.

Anticancer Res. 2001 Mar-Apr;21(2B):1487-94.

PMID:
11396237
20.

Long term results of CHART and weekly Paclitaxel in locally advanced non-small cell lung cancer.

Oral EN.

Lung Cancer. 2005 Sep;49(3):421-2. Epub 2005 Apr 9. No abstract available.

PMID:
16102609

Supplemental Content

Support Center